-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Relapsed Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Enzalutamide in Relapsed Acute Myeloid Leukemia Drug Details: Enzalutamide (Xtandi) is a phenylimidazolidine derivative, acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Refractory Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Enzalutamide in Refractory Acute Myeloid Leukemia Drug Details: Enzalutamide (Xtandi) is a phenylimidazolidine derivative, acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enzalutamide in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Enzalutamide in Refractory Chronic Lymphocytic Leukemia (CLL) Drug Details:Enzalutamide (Xtandi)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Relapsed Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enzalutamide in Relapsed Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Enzalutamide in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug Details:Enzalutamide (Xtandi)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enzalutamide in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Enzalutamide in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drug...
-
Thematic Analysis
Internet of Things (IoT) in Travel and Tourism – Thematic Intelligence
Internet of Things (IoT) in Travel and Tourism Thematic Report Overview The Internet of Things (IoT) has strongly influenced digitalization in the travel and tourism industry. The COVID-19 pandemic brought key IoT use cases to the attention of the travel and tourism industry. The deployment of IoT is further expected to address the ESG challenges across travel and tourism sector. For instance, IoT can address ESG concerns in a host of ways from sensor-enabled smart lighting and thermostats that monitor...
-
Company Profile
ADT Inc – Company Profile
ADT Inc (ADT) is a provider of monitored security, interactive home, and business automation services. The company offers home and business security systems and services for video surveillance, access control, temperature monitoring, flood monitoring, fire and smoke, carbon monoxide monitoring, and other environmental conditions and hazards. It also offers personal emergency response system products and services, maintenance, and installation services. ADT serves owners of single-family homes; retail businesses; medical offices; financial institutions; food and beverage service providers; and professional service...
Add to Basket -
Sector Analysis
Embedded Insurance Market Analysis, Key Trends and Strategies, Line of Business and Future Implications
Access and explore in-depth trends and insights on ‘Embedded Insurance Market’ and use this report to: Determine the primary trends driving embedded insurance across key lines of business. See how the growth of open insurance and digital ecosystems presents a major opportunity for innovative and forward-looking insurance players. Assess the threat and impact of new non-insurance players in the market. Identify key affinity, insurtech, API, and legacy players in the embedded insurance segment from across the industry. Learn the regulatory...
-
Product Insights
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colorectal Cancer Pipeline Products Market Report Overview Colorectal cancer starts in the colon or the rectum. It begins as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools, and weight loss with no known reasons. Risk factors for colorectal cancer include smoking, heavy alcohol use, inflammatory bowel disease (IBD), and family history. Treatment...